Ambu A/S: Ambu’s production exempt from Malaysian movement control order

The Malaysian authorities have granted Ambu – as a manufacturer of medical devices – exemption from the two-week movement control order that has been declared with effect from 18 March, 2020. The nationwide movement control order is an initiative to counter the spread of Covid-19 in Malaysia.

“Our role is to keep supplying hospitals around the globe with devices that help save lives and improve patient care. With the current pressure on national healthcare systems, we do our utmost to make sure that we can keep producing and delivering supplies to hospitals. Therefore, it is positive that the Malaysian authorities recognize the role we play in supporting healthcare facilities,” says Juan Jose Gonzalez, CEO of Ambu.

Contacts

Investors

Michael Højgaard, CFO, tel. , email:

Nicolai Thomsen, Investor Relations Manager, tel. , email:

Media

Mikkel Trier Wagner, Director Corporate Communications, tel. , email:

Attachment